share_log

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga ·  Jan 30 05:31

Gainers

  • Agape ATP (NASDAQ:ATPC) stock increased by 39.2% to $0.71 during Monday's after-market session. The company's market cap stands at $54.7 million.
  • CNS Pharma (NASDAQ:CNSP) stock rose 14.52% to $0.38. The company's market cap stands at $2.3 million.
  • Ekso Bionics Holdings (NASDAQ:EKSO) stock increased by 10.22% to $1.94. The market value of their outstanding shares is at $34.5 million.
  • Oncternal Therapeutics (NASDAQ:ONCT) shares increased by 9.56% to $10.93. The company's market cap stands at $32.3 million.
  • NanoVibronix (NASDAQ:NAOV) stock rose 8.21% to $1.05. The company's market cap stands at $2.1 million.
  • Alaunos Therapeutics (NASDAQ:TCRT) stock moved upwards by 7.79% to $0.17. The company's market cap stands at $40.9 million.

Losers

  • OneMedNet (NASDAQ:ONMD) shares decreased by 12.6% to $1.18 during Monday's after-market session. The company's market cap stands at $38.0 million.
  • Palisade Bio (NASDAQ:PALI) shares declined by 10.95% to $0.85. The market value of their outstanding shares is at $7.9 million.
  • Adaptimmune Therapeutics (NASDAQ:ADAP) stock fell 6.77% to $0.74. The market value of their outstanding shares is at $168.1 million.
  • Butterfly Network (NYSE:BFLY) shares declined by 6.53% to $1.0. The market value of their outstanding shares is at $207.1 million.
  • Soleno Therapeutics (NASDAQ:SLNO) stock declined by 6.11% to $45.06. The company's market cap stands at $1.3 billion.
  • NovaBay Pharmaceuticals (AMEX:NBY) stock decreased by 5.51% to $0.17. The market value of their outstanding shares is at $1.1 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment